| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000004782 |
| Receipt No. | R000005677 |
| Official scientific title of the study | The effect of heart rate control with beta-blocker in the acute phase of myocardial infarction on hemodynamic and functional outcomes. |
| Date of disclosure of the study information | 2010/12/24 |
| Last modified on | 2017/10/24 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The effect of heart rate control with beta-blocker in the acute phase of myocardial infarction on hemodynamic and functional outcomes. | |
| Title of the study (Brief title) | The effect of heart rate control in the acute phase of myocardial infarction on hemodynamic and functional outcomes. | |
| Region |
|
|
| Condition | ||
| Condition | Acute Myocardial Infarction | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the effectiveness of heart rate control with beta-blocker for hemodynamic and cardiac function in the acute phase of myocardial infarction. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | (1) estimated infarct size
(2) left ventricular function (left ventricular ejection fraction ) (3)incidence of arrhythmia (especially atrial fibrillation , ventricular tachycardia and ventricular fibrillation). |
| Key secondary outcomes | (1) survival rate
(2) reperfusion injury (ie, malignant ventricular arrhythmia , re-elevation of ST-segment and worsening of chest pain after reperfusion) (3)cardiovascular events (ie, cardiac death, nonfatal infarction, re-hospitalization because of cardiac disease, revascularization) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Landiolol,Carvedilol | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)first episode of myocardial infarction
(2)ST-elevation myocardial infarction (3)admission to hospital within 12 hours of symptom onset (4) heart rate greater than 90 beats/min on admission (5) emergent primary percutaneous coronary intervention |
|||
| Key exclusion criteria | (1)cardiogenic Shock
(2)severe deterioration of liver function (3)history of beta-blocker or amiodarone treatment (4)history of side effects or contraindication of beta-blocker (5)hypersensitivity to trial medicine (6)doctor's decision not to register to this regimen |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | KATSUOMI IWAKURA |
| Organization | Sakurabashi Watanabe Hospital |
| Division name | Division of Cardiovascular Medicine |
| Address | 2-4-32, Umeda, Kita-ku, Osaka, Japan |
| TEL | 06(6341)8651 |
| Public contact | |
| Name of contact person | YOHEI SOTOMI |
| Organization | Sakurabashi Watanabe Hospital |
| Division name | Division of Cardiovascular Medicine |
| Address | 2-4-32, Umeda, Kita-ku, Osaka, Japan |
| TEL | 06(6341)8651 |
| Homepage URL | |
| Sponsor | |
| Institute | Sakurabashi Watanabe Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005677 |